Home ➤ Life Science ➤ Diagnostics ➤ Diagnostic Radiopharmaceuticals and Contrast Media Market
Diagnostic Radiopharmaceuticals and Contrast Media Market
Published date: July 2026 • Formats:
[email protected] +1 718 874 1545
Request Sample Schedule a Call
Table of Contents

Diagnostic Radiopharmaceuticals and Contrast Media Market By Product Type (Contrast Media, Diagnostic Radiopharmaceuticals), By Contrast Media Type (Iodinated Contrast Media, Gadolinium-Based Contrast Media, Barium-Based Contrast Media, Microbubble Contrast Agents), By Radiopharmaceutical Type (PET Radiopharmaceuticals, SPECT Radiopharmaceuticals, Others), By Application (Oncology Diagnostics, Cardiology Diagnostics, Neurology Diagnostics, Gastrointestinal Imaging, Others), By Imaging Modality (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), SPECT Imaging, Ultrasound Imaging), By End User (Hospitals, Diagnostic Imaging Centers, Research Institutes), By Distribution Channel (Direct Institutional Sales, Specialty Distributors, Online Procurement & Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) and Companies — Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026–2035

  • Published date: July 2026
  • Report ID: 189523
  • Number of Pages: 239
  • Format:
Fact Checked
Global Diagnostic Radiopharmaceuticals and Contrast Media Market https://market.us/report/diagnostic-radiopharmaceuticals-and-contrast-media-market/
Cite this Research
  • keyboard_arrow_up

  • Table of Content

    • 1. Research Methodology and Data Source
      • 1.1. Methodology/Research Approach
      • 1.2. Market Size Estimation
      • 1.3. Market Breakdown and Data Triangulation
      • 1.4. Data Sources
      • 1.5. Secondary Sources
      • 1.6. Primary Sources
    • 2. Executive Summary
      • 2.1. Taxonomy
      • 2.2. Global Market Outlook
      • 2.3. Key Facts and Figures
      • 2.4. Major Players in Diagnostic Radiopharmaceuticals and Contrast Media Market
    • 3. Global Market Overview
      • 3.1. Industry Overview
      • 3.2. Segmental Overview
      • 3.3. Regional Overview
      • 3.4. Market Dynamics
        • 3.4.1. Drivers
        • 3.4.2. Restraints
        • 3.4.3. Opportunities
        • 3.4.4. Trends
      • 3.5. Regulatory Framework
      • 3.6. Opportunity Map Analysis
      • 3.7. Opportunity Orbits
      • 3.8. Market Investment Feasibility Index
      • 3.9. PESTLE Analysis
      • 3.10. PORTER’S Five Force Analysis
      • 3.11. Drivers & Restraints Impact Analysis
      • 3.12. Patient Journey Mapping
      • 3.13. Technological Landscape
      • 3.14. Product Life Cycle Analysis
      • 3.15. Value Chain Analysis
        • 3.15.1. List of Raw Material Suppliers
        • 3.15.2. List of Diagnostic Radiopharmaceuticals and Contrast Media Manufacturers
        • 3.15.3. List of Dealer/Distributors
        • 3.15.4. List of Potential Customers
      • 3.16. Cost Structure Analysis
      • 3.17. Regional Market Share and BPS Analysis
    • 4. Macro-economic Factors
    • 5. Impact of Current Geopolitical Scenario
    • 6. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Analysis and Forecast, By Product Type
      • 6.1. Key Findings
      • 6.2. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 6.2.1. Contrast Media
        • 6.2.2. Diagnostic Radiopharmaceuticals
      • 6.3. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Product Type
    • 7. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Analysis and Forecast, By Contrast Media Type
      • 7.1. Key Findings
      • 7.2. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 7.2.1. Iodinated Contrast Media
        • 7.2.2. Gadolinium-Based Contrast Media
        • 7.2.3. Barium-Based Contrast Media
        • 7.2.4. Microbubble Contrast Agents
      • 7.3. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Contrast Media Type
    • 8. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Analysis and Forecast, By Radiopharmaceutical Type
      • 8.1. Key Findings
      • 8.2. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 8.2.1. PET Radiopharmaceuticals
        • 8.2.2. SPECT Radiopharmaceuticals
        • 8.2.3. Others
      • 8.3. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Radiopharmaceutical Type
    • 9. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Analysis and Forecast, By Distribution Channel
      • 9.1. Key Findings
      • 9.2. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 9.2.1. Oncology Diagnostics
        • 9.2.2. Cardiology Diagnostics
        • 9.2.3. Neurology Diagnostics
        • 9.2.4. Gastrointestinal Imaging
        • 9.2.5. Others
      • 9.3. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
    • 10. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Analysis and Forecast, By Imaging Modality
      • 10.1. Key Findings
      • 10.2. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 10.2.1. Computed Tomography (CT)
        • 10.2.2. Magnetic Resonance Imaging (MRI)
        • 10.2.3. Positron Emission Tomography (PET)
        • 10.2.4. SPECT Imaging
        • 10.2.5. Ultrasound Imaging
      • 10.3. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Imaging Modality
    • 11. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Analysis and Forecast, By End User
      • 11.1. Key Findings
      • 11.2. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 11.2.1. Hospitals
        • 11.2.2. Diagnostic Imaging Centers
        • 11.2.3. Research Institutes
      • 11.3. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By End User
    • 12. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Analysis and Forecast, By Distribution Channel
      • 12.1. Key Findings
      • 12.2. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 12.2.1. Direct Institutional Sales
        • 12.2.2. Specialty Distributors
        • 12.2.3. Online Procurement & Others
      • 12.3. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
    • 13. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Analysis and Forecast, By Region
      • 13.1. Key Findings
      • 13.2. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Region, 2020-2035
        • 13.2.1. North America
        • 13.2.2. Europe
        • 13.2.3. Asia Pacific
        • 13.2.4. Middle East & Africa
        • 13.2.5. Latin America
      • 13.3. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Region
    • 14. North America Diagnostic Radiopharmaceuticals and Contrast Media Market Analysis and Forecast, 2020-2035
      • 14.1. Key Findings
      • 14.2. North America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
      • 14.3. North America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Product Type
      • 14.4. North America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
      • 14.5. North America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Contrast Media Type
      • 14.6. North America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
      • 14.7. North America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Radiopharmaceutical Type
      • 14.8. North America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
      • 14.9. North America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
      • 14.10. North America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
      • 14.11. North America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Imaging Modality
      • 14.12. North America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
      • 14.13. North America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By End User
      • 14.14. North America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
      • 14.15. North America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
      • 14.16. North America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
      • 14.17. North America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Country
        • 14.17.1. The US Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 14.17.2. The US Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 14.17.3. The US Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 14.17.4. The US Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 14.17.5. The US Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 14.17.6. The US Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 14.17.7. The US Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 14.17.8. Canada Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 14.17.9. Canada Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 14.17.10. Canada Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 14.17.11. Canada Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 14.17.12. Canada Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 14.17.13. Canada Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 14.17.14. Canada Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    • 15. Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Analysis and Forecast, 2020-2035
      • 15.1. Key Findings
      • 15.2. Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
      • 15.3. Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Product Type
      • 15.4. Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
      • 15.5. Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Contrast Media Type
      • 15.6. Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
      • 15.7. Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Radiopharmaceutical Type
      • 15.8. Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
      • 15.9. Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
      • 15.10. Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
      • 15.11. Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Imaging Modality
      • 15.12. Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
      • 15.13. Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By End User
      • 15.14. Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
      • 15.15. Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
      • 15.16. Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
      • 15.17. Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Country
        • 15.17.1. Germany Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 15.17.2. Germany Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 15.17.3. Germany Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 15.17.4. Germany Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 15.17.5. Germany Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 15.17.6. Germany Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 15.17.7. Germany Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 15.17.8. The U.K. Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 15.17.9. The U.K. Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 15.17.10. The U.K. Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 15.17.11. The U.K. Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 15.17.12. The U.K. Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 15.17.13. The U.K. Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 15.17.14. The U.K. Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 15.17.15. France Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 15.17.16. France Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 15.17.17. France Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 15.17.18. France Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 15.17.19. France Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 15.17.20. France Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 15.17.21. France Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 15.17.22. Spain Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 15.17.23. Spain Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 15.17.24. Spain Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 15.17.25. Spain Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 15.17.26. Spain Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 15.17.27. Spain Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 15.17.28. Spain Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 15.17.29. Italy Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 15.17.30. Italy Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 15.17.31. Italy Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 15.17.32. Italy Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 15.17.33. Italy Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 15.17.34. Italy Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 15.17.35. Italy Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 15.17.36. Russia & CIS Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 15.17.37. Russia & CIS Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 15.17.38. Russia & CIS Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 15.17.39. Russia & CIS Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 15.17.40. Russia & CIS Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 15.17.41. Russia & CIS Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 15.17.42. Russia & CIS Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 15.17.43. Rest of Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 15.17.44. Rest of Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 15.17.45. Rest of Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 15.17.46. Rest of Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 15.17.47. Rest of Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 15.17.48. Rest of Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 15.17.49. Rest of Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    • 16. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Analysis and Forecast, 2020-2035
      • 16.1. Key Findings
      • 16.2. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
      • 16.3. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Product Type
      • 16.4. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
      • 16.5. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Contrast Media Type
      • 16.6. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
      • 16.7. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Radiopharmaceutical Type
      • 16.8. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
      • 16.9. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
      • 16.10. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
      • 16.11. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Imaging Modality
      • 16.12. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
      • 16.13. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By End User
      • 16.14. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
      • 16.15. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
      • 16.16. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
      • 16.17. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Country
        • 16.17.1. China Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 16.17.2. China Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 16.17.3. China Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 16.17.4. China Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 16.17.5. China Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 16.17.6. China Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 16.17.7. China Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 16.17.8. India Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 16.17.9. India Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 16.17.10. India Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 16.17.11. India Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 16.17.12. India Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 16.17.13. India Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 16.17.14. India Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 16.17.15. Japan Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 16.17.16. Japan Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 16.17.17. Japan Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 16.17.18. Japan Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 16.17.19. Japan Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 16.17.20. Japan Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 16.17.21. Japan Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 16.17.22. South Korea Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 16.17.23. South Korea Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 16.17.24. South Korea Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 16.17.25. South Korea Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 16.17.26. South Korea Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 16.17.27. South Korea Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 16.17.28. South Korea Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 16.17.29. ASEAN Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 16.17.30. ASEAN Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 16.17.31. ASEAN Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 16.17.32. ASEAN Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 16.17.33. ASEAN Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 16.17.34. ASEAN Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 16.17.35. ASEAN Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 16.17.36. Australia & New Zealand Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 16.17.37. Australia & New Zealand Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 16.17.38. Australia & New Zealand Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 16.17.39. Australia & New Zealand Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 16.17.40. Australia & New Zealand Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 16.17.41. Australia & New Zealand Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 16.17.42. Australia & New Zealand Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 16.17.43. Rest of Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 16.17.44. Rest of Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 16.17.45. Rest of Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 16.17.46. Rest of Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 16.17.47. Rest of Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 16.17.48. Rest of Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 16.17.49. Rest of Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    • 17. Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Analysis and Forecast, 2020-2035
      • 17.1. Key Findings
      • 17.2. Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
      • 17.3. Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Product Type
      • 17.4. Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
      • 17.5. Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Contrast Media Type
      • 17.6. Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
      • 17.7. Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Radiopharmaceutical Type
      • 17.8. Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
      • 17.9. Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
      • 17.10. Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
      • 17.11. Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Imaging Modality
      • 17.12. Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
      • 17.13. Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By End User
      • 17.14. Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
      • 17.15. Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
      • 17.16. Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
      • 17.17. Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Country
        • 17.17.1. GCC Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 17.17.2. GCC Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 17.17.3. GCC Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 17.17.4. GCC Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 17.17.5. GCC Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 17.17.6. GCC Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 17.17.7. GCC Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 17.17.8. South Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 17.17.9. South Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 17.17.10. South Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 17.17.11. South Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 17.17.12. South Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 17.17.13. South Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 17.17.14. South Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 17.17.15. Rest of Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 17.17.16. Rest of Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 17.17.17. Rest of Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 17.17.18. Rest of Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 17.17.19. Rest of Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 17.17.20. Rest of Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 17.17.21. Rest of Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    • 18. Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Analysis and Forecast, 2020-2035
      • 18.1. Key Findings
      • 18.2. Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
      • 18.3. Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Product Type
      • 18.4. Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
      • 18.5. Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Contrast Media Type
      • 18.6. Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
      • 18.7. Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Radiopharmaceutical Type
      • 18.8. Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
      • 18.9. Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
      • 18.10. Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
      • 18.11. Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Imaging Modality
      • 18.12. Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
      • 18.13. Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By End User
      • 18.14. Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
      • 18.15. Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
      • 18.16. Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
      • 18.17. Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Country
        • 18.17.1. Brazil Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 18.17.2. Brazil Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 18.17.3. Brazil Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 18.17.4. Brazil Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 18.17.5. Brazil Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 18.17.6. Brazil Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 18.17.7. Brazil Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 18.17.8. Mexico Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 18.17.9. Mexico Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 18.17.10. Mexico Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 18.17.11. Mexico Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 18.17.12. Mexico Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 18.17.13. Mexico Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 18.17.14. Mexico Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 18.17.15. Rest of Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Product Type, 2020-2035
        • 18.17.16. Rest of Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Contrast Media Type, 2020-2035
        • 18.17.17. Rest of Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Radiopharmaceutical Type, 2020-2035
        • 18.17.18. Rest of Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
        • 18.17.19. Rest of Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
        • 18.17.20. Rest of Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
        • 18.17.21. Rest of Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    • 19. Competitive Landscape & Company Profiles
      • 19.1. Market Competition Scenario Analysis, By Company
      • 19.2. Competitor Landscape
      • 19.3. Company Share Analysis
      • 19.4. Company Profiles
        • 19.4.1. GE HealthCare
          • 19.4.1.1. Company Details
          • 19.4.1.2. Business Overview
          • 19.4.1.3. Product Portfolio
          • 19.4.1.4. Financial Insights
          • 19.4.1.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 19.4.1.6. SWOT Analysis
          • 19.4.1.7. Geographic Footprint
        • 19.4.2. Bayer AG
          • 19.4.2.1. Company Details
          • 19.4.2.2. Business Overview
          • 19.4.2.3. Product Portfolio
          • 19.4.2.4. Financial Insights
          • 19.4.2.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 19.4.2.6. SWOT Analysis
          • 19.4.2.7. Geographic Footprint
        • 19.4.3. Bracco Imaging
          • 19.4.3.1. Company Details
          • 19.4.3.2. Business Overview
          • 19.4.3.3. Product Portfolio
          • 19.4.3.4. Financial Insights
          • 19.4.3.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 19.4.3.6. SWOT Analysis
          • 19.4.3.7. Geographic Footprint
        • 19.4.4. Guerbet Group
          • 19.4.4.1. Company Details
          • 19.4.4.2. Business Overview
          • 19.4.4.3. Product Portfolio
          • 19.4.4.4. Financial Insights
          • 19.4.4.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 19.4.4.6. SWOT Analysis
          • 19.4.4.7. Geographic Footprint
        • 19.4.5. Lantheus Holdings
          • 19.4.5.1. Company Details
          • 19.4.5.2. Business Overview
          • 19.4.5.3. Product Portfolio
          • 19.4.5.4. Financial Insights
          • 19.4.5.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 19.4.5.6. SWOT Analysis
          • 19.4.5.7. Geographic Footprint
        • 19.4.6. Curium Pharma
          • 19.4.6.1. Company Details
          • 19.4.6.2. Business Overview
          • 19.4.6.3. Product Portfolio
          • 19.4.6.4. Financial Insights
          • 19.4.6.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 19.4.6.6. SWOT Analysis
          • 19.4.6.7. Geographic Footprint
        • 19.4.7. Cardinal Health
          • 19.4.7.1. Company Details
          • 19.4.7.2. Business Overview
          • 19.4.7.3. Product Portfolio
          • 19.4.7.4. Financial Insights
          • 19.4.7.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 19.4.7.6. SWOT Analysis
          • 19.4.7.7. Geographic Footprint
        • 19.4.8. Jubilant Radiopharma
          • 19.4.8.1. Company Details
          • 19.4.8.2. Business Overview
          • 19.4.8.3. Product Portfolio
          • 19.4.8.4. Financial Insights
          • 19.4.8.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 19.4.8.6. SWOT Analysis
          • 19.4.8.7. Geographic Footprint
        • 19.4.9. Siemens Healthineers
          • 19.4.9.1. Company Details
          • 19.4.9.2. Business Overview
          • 19.4.9.3. Product Portfolio
          • 19.4.9.4. Financial Insights
          • 19.4.9.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 19.4.9.6. SWOT Analysis
          • 19.4.9.7. Geographic Footprint
        • 19.4.10. Eckert & Ziegler
          • 19.4.10.1. Company Details
          • 19.4.10.2. Business Overview
          • 19.4.10.3. Product Portfolio
          • 19.4.10.4. Financial Insights
          • 19.4.10.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 19.4.10.6. SWOT Analysis
          • 19.4.10.7. Geographic Footprint
        • 19.4.11. Nordion
          • 19.4.11.1. Company Details
          • 19.4.11.2. Business Overview
          • 19.4.11.3. Product Portfolio
          • 19.4.11.4. Financial Insights
          • 19.4.11.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 19.4.11.6. SWOT Analysis
          • 19.4.11.7. Geographic Footprint
        • 19.4.12. Telix Pharmaceuticals
          • 19.4.12.1. Company Details
          • 19.4.12.2. Business Overview
          • 19.4.12.3. Product Portfolio
          • 19.4.12.4. Financial Insights
          • 19.4.12.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 19.4.12.6. SWOT Analysis
          • 19.4.12.7. Geographic Footprint
        • 19.4.13. Novartis AG
          • 19.4.13.1. Company Details
          • 19.4.13.2. Business Overview
          • 19.4.13.3. Product Portfolio
          • 19.4.13.4. Financial Insights
          • 19.4.13.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 19.4.13.6. SWOT Analysis
          • 19.4.13.7. Geographic Footprint
        • 19.4.14. Philips Healthcare
          • 19.4.14.1. Company Details
          • 19.4.14.2. Business Overview
          • 19.4.14.3. Product Portfolio
          • 19.4.14.4. Financial Insights
          • 19.4.14.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 19.4.14.6. SWOT Analysis
          • 19.4.14.7. Geographic Footprint
        • 19.4.15. FUJIFILM Holdings
          • 19.4.15.1. Company Details
          • 19.4.15.2. Business Overview
          • 19.4.15.3. Product Portfolio
          • 19.4.15.4. Financial Insights
          • 19.4.15.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 19.4.15.6. SWOT Analysis
          • 19.4.15.7. Geographic Footprint

    List of Tables

    • Table 1: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 2: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 3: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 4: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 5: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 6: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 7: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 8: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Region, 2020-2035
    • Table 9: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 10: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 11: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 12: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 13: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 14: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 15: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 16: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Country, 2020-2035
    • Table 17: The US Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 18: The US Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 19: The US Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 20: The US Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 21: The US Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 22: The US Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 23: The US Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 24: Canada Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 25: Canada Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 26: Canada Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 27: Canada Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 28: Canada Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 29: Canada Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 30: Canada Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 31: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 32: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 33: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 34: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 35: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 36: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 37: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 38: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Country, 2020-2035
    • Table 39: Germany Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 40: Germany Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 41: Germany Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 42: Germany Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 43: Germany Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 44: Germany Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 45: Germany Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 46: The U.K. Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 47: The U.K. Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 48: The U.K. Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 49: The U.K. Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 50: The U.K. Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 51: The U.K. Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 52: The U.K. Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 53: France Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 54: France Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 55: France Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 56: France Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 57: France Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 58: France Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 59: France Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 60: Spain Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 61: Spain Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 62: Spain Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 63: Spain Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 64: Spain Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 65: Spain Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 66: Spain Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 67: Italy Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 68: Italy Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 69: Italy Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 70: Italy Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 71: Italy Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 72: Italy Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 73: Italy Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 74: Russia & CIS Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 75: Russia & CIS Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 76: Russia & CIS Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 77: Russia & CIS Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 78: Russia & CIS Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 79: Russia & CIS Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 80: Russia & CIS Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 81: Rest of Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 82: Rest of Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 83: Rest of Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 84: Rest of Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 85: Rest of Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 86: Rest of Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 87: Rest of Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 88: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 89: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 90: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 91: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 92: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 93: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 94: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 95: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Country, 2020-2035
    • Table 96: China Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 97: China Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 98: China Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 99: China Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 100: China Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 101: China Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 102: China Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 103: India Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 104: India Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 105: India Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 106: India Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 107: India Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 108: India Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 109: India Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 110: Japan Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 111: Japan Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 112: Japan Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 113: Japan Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 114: Japan Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 115: Japan Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 116: Japan Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 117: South Korea Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 118: South Korea Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 119: South Korea Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 120: South Korea Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 121: South Korea Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 122: South Korea Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 123: South Korea Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 124: ASEAN Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 125: ASEAN Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 126: ASEAN Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 127: ASEAN Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 128: ASEAN Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 129: ASEAN Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 130: ASEAN Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 131: Australia & New Zealand Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 132: Australia & New Zealand Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 133: Australia & New Zealand Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 134: Australia & New Zealand Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 135: Australia & New Zealand Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 136: Australia & New Zealand Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 137: Australia & New Zealand Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 138: Rest of Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 139: Rest of Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 140: Rest of Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 141: Rest of Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 142: Rest of Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 143: Rest of Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 144: Rest of Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 145: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 146: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 147: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 148: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 149: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 150: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 151: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 152: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Country, 2020-2035
    • Table 153: GCC Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 154: GCC Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 155: GCC Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 156: GCC Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 157: GCC Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 158: GCC Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 159: GCC Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 160: South Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 161: South Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 162: South Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 163: South Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 164: South Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 165: South Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 166: South Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 167: Rest of Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 168: Rest of Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 169: Rest of Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 170: Rest of Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 171: Rest of Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 172: Rest of Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 173: Rest of Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 174: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 175: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 176: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 177: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 178: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 179: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 180: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 181: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Country, 2020-2035
    • Table 182: Brazil Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 183: Brazil Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 184: Brazil Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 185: Brazil Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 186: Brazil Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 187: Brazil Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 188: Brazil Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 189: Mexico Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 190: Mexico Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 191: Mexico Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 192: Mexico Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 193: Mexico Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 194: Mexico Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 195: Mexico Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 196: Rest of Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Product Type, 2020-2035
    • Table 197: Rest of Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Contrast Media Type, 2020-2035
    • Table 198: Rest of Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Radiopharmaceutical Type, 2020-2035
    • Table 199: Rest of Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035
    • Table 200: Rest of Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Imaging Modality, 2020-2035
    • Table 201: Rest of Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By End User, 2020-2035
    • Table 202: Rest of Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), By Distribution Channel, 2020-2035

    List of Figures

    • Figure 1: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value (US$ Bn), 2020-2035
    • Figure 2: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Product Type, 2025 & 2035
    • Figure 3: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Contrast Media Type, 2025 & 2035
    • Figure 4: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Radiopharmaceutical Type, 2025 & 2035
    • Figure 5: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Distribution Channel, 2025 & 2035
    • Figure 6: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Imaging Modality, 2025 & 2035
    • Figure 7: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By End User, 2025 & 2035
    • Figure 8: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Distribution Channel, 2025 & 2035
    • Figure 9: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Region, 2025 & 2035
    • Figure 10: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Product Type, 2020, 2025 and 2035
    • Figure 11: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Product Type
    • Figure 12: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Contrast Media Type, 2020, 2025 and 2035
    • Figure 13: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Contrast Media Type
    • Figure 14: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Radiopharmaceutical Type, 2020, 2025 and 2035
    • Figure 15: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Radiopharmaceutical Type
    • Figure 16: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
    • Figure 17: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
    • Figure 18: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Imaging Modality, 2020, 2025 and 2035
    • Figure 19: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Imaging Modality
    • Figure 20: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
    • Figure 21: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By End User
    • Figure 22: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
    • Figure 23: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
    • Figure 24: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Region, 2020, 2025 and 2035
    • Figure 25: Global Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Region
    • Figure 26: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Product Type, 2020, 2025 and 2035
    • Figure 27: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Product Type
    • Figure 28: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Contrast Media Type, 2020, 2025 and 2035
    • Figure 29: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Contrast Media Type
    • Figure 30: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Radiopharmaceutical Type, 2020, 2025 and 2035
    • Figure 31: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Radiopharmaceutical Type
    • Figure 32: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
    • Figure 33: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
    • Figure 34: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Imaging Modality, 2020, 2025 and 2035
    • Figure 35: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Imaging Modality
    • Figure 36: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
    • Figure 37: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By End User
    • Figure 38: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
    • Figure 39: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
    • Figure 40: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
    • Figure 41: North America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Country
    • Figure 42: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Product Type, 2020, 2025 and 2035
    • Figure 43: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Product Type
    • Figure 44: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Contrast Media Type, 2020, 2025 and 2035
    • Figure 45: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Contrast Media Type
    • Figure 46: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Radiopharmaceutical Type, 2020, 2025 and 2035
    • Figure 47: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Radiopharmaceutical Type
    • Figure 48: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
    • Figure 49: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
    • Figure 50: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Imaging Modality, 2020, 2025 and 2035
    • Figure 51: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Imaging Modality
    • Figure 52: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
    • Figure 53: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By End User
    • Figure 54: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
    • Figure 55: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
    • Figure 56: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
    • Figure 57: Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Country
    • Figure 58: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Product Type, 2020, 2025 and 2035
    • Figure 59: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Product Type
    • Figure 60: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Contrast Media Type, 2020, 2025 and 2035
    • Figure 61: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Contrast Media Type
    • Figure 62: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Radiopharmaceutical Type, 2020, 2025 and 2035
    • Figure 63: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Radiopharmaceutical Type
    • Figure 64: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
    • Figure 65: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
    • Figure 66: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Imaging Modality, 2020, 2025 and 2035
    • Figure 67: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Imaging Modality
    • Figure 68: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
    • Figure 69: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By End User
    • Figure 70: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
    • Figure 71: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
    • Figure 72: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
    • Figure 73: Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Country
    • Figure 74: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Product Type, 2020, 2025 and 2035
    • Figure 75: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Product Type
    • Figure 76: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Contrast Media Type, 2020, 2025 and 2035
    • Figure 77: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Contrast Media Type
    • Figure 78: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Radiopharmaceutical Type, 2020, 2025 and 2035
    • Figure 79: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Radiopharmaceutical Type
    • Figure 80: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
    • Figure 81: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
    • Figure 82: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Imaging Modality, 2020, 2025 and 2035
    • Figure 83: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Imaging Modality
    • Figure 84: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
    • Figure 85: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By End User
    • Figure 86: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
    • Figure 87: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
    • Figure 88: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
    • Figure 89: Middle East & Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Country
    • Figure 90: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Product Type, 2020, 2025 and 2035
    • Figure 91: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Product Type
    • Figure 92: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Contrast Media Type, 2020, 2025 and 2035
    • Figure 93: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Contrast Media Type
    • Figure 94: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Radiopharmaceutical Type, 2020, 2025 and 2035
    • Figure 95: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Radiopharmaceutical Type
    • Figure 96: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
    • Figure 97: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
    • Figure 98: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Imaging Modality, 2020, 2025 and 2035
    • Figure 99: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Imaging Modality
    • Figure 100: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
    • Figure 101: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By End User
    • Figure 102: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
    • Figure 103: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Distribution Channel
    • Figure 104: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
    • Figure 105: Latin America Diagnostic Radiopharmaceuticals and Contrast Media Market Attractiveness Analysis, By Country
    • GE HealthCare
    • Bayer AG
    • Bracco Imaging S.p.A.
    • Guerbet Group
    • Lantheus Holdings Inc.
    • Curium Pharma
    • Cardinal Health Inc.
    • Jubilant Radiopharma
    • Siemens Healthineers AG
    • Eckert & Ziegler AG
    • Nordion (Canada) Inc.
    • Telix Pharmaceuticals Limited
    • Novartis AG
    • Philips Healthcare
    • FUJIFILM Holdings Corporation
    • Other Key Players
Diagnostic Radiopharmaceuticals and Contrast Media Market
Diagnostic Radiopharmaceuticals and Contrast Media Market
Published date: July 2026
add_shopping_cartBuy Now get_appDownload Sample

Related Reports

Diagnostic Radiopharmaceuticals and Contrast Media Market
  • 189523
  • July 2026
    • ★★★★★
      ★★★★★
Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo

Our Clients

✖
Request a Sample Report
We'll get back to you as quickly as possible

✖
Request a Sample Report
We'll get back to you as quickly as possible

Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options